Editas Medicine (EDIT) Net Margin Growth (5y) (2020 - 2025)
Editas Medicine (EDIT) Net Margin Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -41,374.00 |
| Jun 30, 2025 | -123,297.00 |
| Mar 31, 2025 | -103,369.00 |
| Dec 31, 2024 | 11,743.00 |
| Sep 30, 2024 | -10.10 Mn |
| Jun 30, 2024 | -1.17 Mn |
| Mar 31, 2024 | -438,394.00 |
| Dec 31, 2023 | 37,543.00 |
| Sep 30, 2023 | -238,416.00 |
| Jun 30, 2023 | -1.70 Mn |
| Mar 31, 2023 | -209,466.00 |
| Dec 31, 2022 | -47,409.00 |
| Sep 30, 2022 | -378.51 Mn |
| Jun 30, 2022 | -1.59 Mn |
| Mar 31, 2022 | -5.46 Mn |
| Dec 31, 2021 | 411,445.00 |
| Sep 30, 2021 | 109,579.00 |
| Jun 30, 2021 | -3.39 Mn |
| Mar 31, 2021 | 66,998.00 |
| Dec 31, 2020 | 106,025.00 |